Involvement of Beclin‑1 in axonal protection by short‑term hyperglycemia against TNF‑induced optic nerve damage

Area of Science:

• Neuroscience
• Cell Biology
• Autophagy Research

Background:

• Beclin-1 is essential for autophagosome formation.
• Streptozotocin-induced hyperglycemia (HG) has been shown to reduce axonal loss caused by tumor necrosis factor (TNF) by upregulating autophagy.
• The role of Beclin-1 in this HG-mediated autophagy and neuroprotection is not fully understood.

Purpose of the Study:

• To investigate the involvement of Beclin-1 in the autophagy machinery during HG-induced neuroprotection.
• To determine if HG upregulates Beclin-1 expression in the optic nerve.
• To assess the contribution of Beclin-1 to the ameliorative effects of HG on axonal loss.

Main Methods:

• Immunoblot analysis of optic nerve Beclin-1 protein expression in normoglycemic (NG) and hyperglycemic (HG) rats.
• Intravitreal administration of TNF in NG and HG rats.
• Immunoreactivity staining for Beclin-1 in optic nerves.
• Morphometric analysis of axon loss.
• Intervention with Beclin-1 small interfering RNA (siRNA).

Main Results:

• HG significantly upregulated Beclin-1 protein expression in the optic nerve compared to NG.
• TNF administration did not affect Beclin-1 expression in either NG or HG conditions.
• Beclin-1 immunoreactivity was primarily observed in astrocytes, with additional presence in neurofilaments in the HG group.
• HG demonstrated substantial ameliorative effects on axon loss.
• Beclin-1 siRNA partially reversed the protective effect of HG on axon loss.

Conclusions:

• Beclin-1 is present in both neurons and glia within the optic nerve.
• Increased Beclin-1 expression, potentially mediated by HG, is associated with axonal protection.
• Beclin-1 plays a partial role in the neuroprotective mechanisms of hyperglycemia.